SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-21-143695
Filing Date
2021-04-30
Accepted
2021-04-30 12:32:55
Documents
5

Document Format Files

Seq Description Document Type Size
1 DEFA14A d175642ddefa14a.htm DEFA14A 36720
2 GRAPHIC g175642g01a44.jpg GRAPHIC 133040
3 GRAPHIC g175642g01a58.jpg GRAPHIC 56980
4 GRAPHIC g175642g01w97.jpg GRAPHIC 16633
5 GRAPHIC g175642g02b33.jpg GRAPHIC 9580
  Complete submission text file 0001193125-21-143695.txt   335881
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-24006 | Film No.: 21875551
SIC: 2834 Pharmaceutical Preparations